Navigation Links
MS patients more compliant with medications when managed by specialty pharmacy
Date:5/20/2009

ORLANDO, Fla.May 19, 2009Multiple sclerosis patients managed by a specialty pharmacy program were more compliant with medication, and had a lower risk of being hospitalized for their disease than those who were not managed by a specialty pharmacy program, according to a study completed by HealthCore, Inc.

HealthCore researcher Jingbo Yu presented the study today at the International Society of Pharmacoeconomic and Outcomes Research 14th Annual International Meeting in Orlando, Fla. The retrospective study analyzed medical and pharmacy claims data.

The HealthCore study compared 3,055 patients managed by PrecisionRx Specialty Solutions to 807 patients who were not part of a specialty pharmacy-managed group over a period of one year. PrecisionRx provided patient education materials, regularly scheduled nurse calls and refill reminders to its members.

The study showed that those in the managed group had a 47 percent lower risk of being hospitalized to treat conditions associated with MS compared to the non-managed group.

Average overall MS-related total cost of care for one year was $20,105 for the managed group versus $16,857 for the non-managed group. The difference was driven by improved persistence with medications. Over time, the average MS-related medical cost decreased $270 among the managed patients, while it increased $1,245 among the un-managed group.

The study showed that the overall cost of care among the group managed by PrecisionRx Specialty Solutions, a subsidiary of WellPoint Inc., was higher because these members adhered better to their MS medication, which is costly. Reduced short-term disability costs, improved presenteeism and productivity were not directly assessed in the study, but likely are significant due to the significantly decreased utilization of medical services.

"Outcomes are clearly better for patients when they receive more sophisticated support and education that is encouraging them to stay compliant with their medication," said Dr. Joseph Singer, vice president of clinical affairs for HealthCore, the research outcomes subsidiary for WellPoint Inc. "It's well-documented that these drugs keep patients healthier and functioning at a higher level for a much longer period of time than if they weren't taking these drugs, despite their common side effects."

Multiple sclerosis is a chronic and progressive inflammatory disease of the central nervous system that affects about 400,000 people in the United States. The medications currently available to treat MS are effective in reducing relapses but are associated with side effects that reduce their tolerability. Those patients managed by PrecisionRx achieved a length of continuous therapy over 290 days compared to 209 days by the non-managed group, which was statistically and clinically significant.

"Because MS drugs have significant side effects, the regularly scheduled nurse calls-at three, six and then 12 months, can make a huge difference in how that member continues with therapy," said Tracy Nolan, vice president of PrecisionRx Specialty Solutions. "We develop relationships with members that open the door to them sharing with us issues they may have in being compliant. By knowing what those problems are, we can often help them figure out a solution."


'/>"/>

Contact: Lori McLaughlin
lori.mclaughlin2@wellpoint.com
317-407-7403
HealthCore
Source:Eurekalert

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... January 15, 2017 , ... Going above and beyond the ... to better communities around the world by offering the Gensuite team and their ... for team members to become involved in a cause that is bigger than ...
(Date:1/15/2017)... ... January 15, 2017 , ... Accreditation Commission for ... for its specialty care services. Albertsons Companies is the largest national food ... for pharmacy patients. , Accreditation by ACHC reflects Albertsons Companies’ dedication and commitment ...
(Date:1/15/2017)... ... January 15, 2017 , ... ... best physicians in eight Bay Area counties for 2017. Almost 1,000 nominations were ... company managing the award process. Results were announced the magazine’s January 2017 ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor Rock Climbing Gym ... construction wraps up on the 14,000+ square foot climbing gym, the owners anticipate to ... three in New Jersey and two in New York. With this being its first ...
(Date:1/14/2017)... MN (PRWEB) , ... January 14, 2017 , ... ... present the distinctions among their expanding line of activated charcoal products. With more ... the importance of categorizing their products according to how they cater to specific ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... 16, 2017  According to Kalorama Information, the ... valued at $4.9 billion for 2016.  The growing ... an aging population with significant diagnostic needs, along ... propelling the market for the modality.  The healthcare ... , focuses on the worldwide market, providing market ...
(Date:1/16/2017)... , January 16, 2017 ... Derivatives Market by Product Type (Methyl, Ethyl, Hydroxyethyl, ... Foods & Beverages, Surface Coatings & Paints), ... by MarketsandMarkets, the market was valued at ... projected to reach USD 6.41 Billion by ...
(Date:1/16/2017)... CRUZ, Calif. , Jan. 16, 2017  Dovetail ... Dovetail™ Hi-C sequencing and assembly service, which yields chromosome-scale ... be presented in a Dovetail-hosted workshop on Jan. 17 ... in San Diego . ... services with the launch of our Dovetail Hi-C offering," ...
Breaking Medicine Technology: